AtaiBeckley (ATAI) Profit After Tax (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Profit After Tax came in at -$61.1 million in Q3 2025, down 132.21% year-on-year from $189.7 million in Q3 2024, and down 120.2% quarter-over-quarter from -$27.7 million in Q2 2025.
AtaiBeckley (ATAI) Profit After Tax (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Profit After Tax across 6 years of filings, most recently posting -$61.1 million for Q3 2025.
- Profit After Tax for Q3 2025 came in at -$61.1 million, down 132.21% year-over-year; the trailing twelve-month figure through Sep 2025 was -$116.3 million (down 106.01% YoY), and the FY2024 annual result was -$150.0 million, down 241.84% from the prior year.
- Profit After Tax was -$29.8 million for Q1 2026 at AtaiBeckley, down from -$26.4 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$960000.0 in Q4 2024 to a low of -$29.8 million in Q1 2026.
- Historically, Profit After Tax has averaged -$19.1 million across 3 years, with a median of -$26.4 million in 2025.
- Across the five-year window, Profit After Tax tumbled 1028.73% in 2022 and surged 223.93% in 2023, its largest moves.
- A 3-year view of Profit After Tax shows it stood at -$960000.0 in 2024, then tumbled by 2653.23% to -$26.4 million in 2025, then slipped by 12.75% to -$29.8 million in 2026.
- The last three Profit After Tax figures came in at -$29.8 million (Q1 2026), -$26.4 million (Q1 2025), and -$960000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -29.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.80 Mn |
| Sep 30, 2025 | -61.10 Mn |
| Jun 30, 2025 | -27.75 Mn |
| Mar 31, 2025 | -26.47 Mn |
| Mar 31, 2025 | -26.43 Mn |
| Dec 31, 2024 | -960,000.00 |
| Dec 31, 2024 | -960,000.00 |
| Sep 30, 2024 | -26.31 Mn |
| Jun 30, 2024 | -57.37 Mn |
| Mar 31, 2024 | -27.38 Mn |
| Dec 31, 2023 | 54.62 Mn |
| Sep 30, 2023 | 44.24 Mn |
| Jun 30, 2023 | -33.77 Mn |
| Mar 31, 2023 | -34.35 Mn |
| Dec 31, 2022 | -50.04 Mn |
| Sep 30, 2022 | -35.70 Mn |
| Jun 30, 2022 | -37.51 Mn |
| Mar 31, 2022 | -37.56 Mn |
| Dec 31, 2021 | -90.72 Mn |
| Sep 30, 2021 | -31.64 Mn |